Moxifloxacin Online



How and where to order Avelox (Moxifloxacin) 400 mg tablets or capsules online on Respiratory Tract Infection Alert website:

Shop:MEDICINES STORE
Stores:PHARMA DOCTOR
Prices:from $2.25 per pill
Discount:10% coupon: MSD10
Forms:Moxifloxacin (Avelox) 400 mg tablets
Quantity:10-90 pills
Type:Moxifloxacin brand, Avelox generic
Payment:Visa, MasterCard, AmEx, E-Check (ACH), Bitcoin
Delivery:Regular and express mail service
Shipping:Worldwide, including USA, UK, Europe, Canada, Australia


Moxifloxacin (trade names include Avelox, Mediflox, Zymox, Avalox, Actira, Izilox, Moxeza, Moxicip, Octegra, Proflox, Vigamox) is a broad spectrum quinolone antibacterial medication from fluoroquinolones pharmacological group. This medicine is used for the treatment and prophylaxis of various kinds of infections such as complicated and uncomplicated skin, skin structure, soft tissue, eyes, intra-abdominal, respiratory tract infections. Indication include pneumonia, chronic bronchitis, chronic obstructive pulmonary disease (COPD), sinusitis, meningitis, conjunctivitis, endocarditis, prostatitis, tuberculosis, cellulitis, anthrax, plague, in veterinary medicine. The spectrum of action includes Gram-positive and Gram-negative bacteria: Bacillus anthracis, Enterobacter spp., Haemophilus influenzae, Klebsiella spp., Moraxella catarrhalis, Mycobacterium spp., Mycoplasma genitalium, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae. It works by inhibiting enzymes necessary to separate bacterial DNA, thereby inhibiting cell replication.


Avelox (Moxifloxacin) logo


Related medications:

  • Amoxicillin (Amoxil)
  • Amoxicillin, Clavulanate (Augmentin)
  • Azithromycin (Zithromax)
  • Cefaclor (Ceclor)
  • Cefixime (Suprax)
  • Cefuroxime (Ceftin)
  • Chloramphenicol (Chloromycetin)
  • Ciprofloxacin (Ciloxan, Cipro)
  • Clarithromycin (Biaxin)
  • Clindamycin (Cleocin)
  • Doxycycline (Vibramycin)
  • Enoxacin (Enoxor)
  • Erythromycin (Ilosone)
  • Fleroxacin (Quinodis)
  • Garenoxacin (Geninax)
  • Gatifloxacin (Zymar)
  • Gemifloxacin (Factive)
  • Grepafloxacin (Raxar)
  • Levofloxacin (Levaquin)
  • Linezolid (Zyvox)
  • Lomefloxacin (Maxaquin)
  • Metronidazole (Flagyl)
  • Minocycline (Minocin)
  • Norfloxacin (Noroxin)
  • Ofloxacin (Floxin)
  • Pazufloxacin (Pazucross)
  • Pefloxacin (Peflacine)
  • Prulifloxacin (Superquin)
  • Roxithromycin (Rulide)
  • Rufloxacin (Uroflox)
  • Sitafloxacin (Gracevit)
  • Sparfloxacin (Sparlox)
  • Sulfamethoxazole, Trimethoprim (Bactrim)
  • Temafloxacin (Omniflox)
  • Tetracycline (Sumycin)
  • Trovafloxacin (Trovan)


    Pharmacological and medical categories:

  • Anti infective agents
  • Anti tubercular drugs
  • Antibacterial medications
  • Antibiotics
  • Eye anti-infectives and antiseptics
  • Gyrase inhibitors
  • Quinolones
  • Veterinary, pet meds


    ATC codes:

  • J - Antiinfectives for systemic use
  • J01 - Antibacterials for systemic use
  • J01M - Quinolone antibacterials
  • J01MA - Fluoroquinolones
  • J01MA14 - Moxifloxacin

  • S - Sensory organs
  • S01 - Ophthalmologicals
  • S01A - Antiinfectives
  • S01AE - Fluoroquinolones
  • S01AE07 - Moxifloxacin


    ICD-10 codes:

  • Tuberculosis - A15-A19
  • Plague - A20
  • Anthrax - A22
  • Meningitis due to other and unspecified causes - G03
  • Conjunctivitis - H10
  • Acute and subacute endocarditis - I33
  • Acute sinusitis - J01
  • Influenza and pneumonia - J09-J18
  • Bacterial pneumonia, not elsewhere classified - J15
  • Pneumonia, unspecified organism - J18
  • Chronic lower respiratory diseases - J40-J47
  • Unspecified chronic bronchitis - J42
  • Other chronic obstructive pulmonary disease - J44
  • Impetigo - L01
  • Cutaneous abscess, furuncle and carbuncle - L02
  • Cellulitis - L03
  • Other local infections of skin and subcutaneous tissue - L08
  • Inflammatory diseases of prostate - N41


    Indications and usage:

    Moxifloxacin (Avelox) is a fluoroquinolone antibacterial indicated for treating infections in adults 18 years of age and older caused by designated susceptible bacteria, in the conditions listed below:

  • Community acquired pneumonia
  • Skin and skin structure infections: uncomplicated and complicated
  • Complicated intra-abdominal infections
  • Plague
  • Acute bacterial sinusitis
  • Acute bacterial exacerbation of chronic bronchitis

    To reduce the development of drug-resistant bacteria and maintain the effectiveness of Avelox and other antibacterial drugs. Moxifloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.


    Dosage and administration:

    The dose of Moxifloxacin (Avelox) is 400 mg every 24 hours for all types of infection:

  • Community acquired pneumonia: 714 days
  • Uncomplicated skin and skin structure infections (SSSI): 7 days
  • Complicated SSSI: 721 days
  • Complicated intra-abdominal infections: 514 days
  • Plague: 1014 days
  • Acute bacterial sinusitis: 10 days
  • Acute bacterial exacerbation of chronic bronchitis: 5 days


    Dosage forms and strengt:

  • Avelox tablets: moxifloxacin hydrochloride (equivalent to 400 mg moxifloxacin).
  • Avelox injection: moxifloxacin hydrochloride (equivalent to 400 mg moxifloxacin) in 0.8% sodium chloride solution in a 250 mL flexibag.


    Overdosage:

    Single oral overdoses up to 2.8 g of Moxifloxacin (Avelox) were not associated with any serious adverse events. In the event of acute overdose, empty the stomach and maintain adequate hydration. Monitor ECG due to the possibility of QT interval prolongation. Carefully observe the patient and give supportive treatment. The administration of activated charcoal as soon as possible after oral overdose may prevent excessive increase of systemic moxifloxacin exposure. About 3% and 9% of the dose of moxifloxacin, as well as about 2% and 4.5% of its glucuronide metabolite are removed by continuous ambulatory peritoneal dialysis and hemodialysis, respectively.


    Contraindications:

    Known hypersensitivity to Avelox (Moxifloxacin) or other quinolones.


    Warnings and precautions:

  • Prolongation of the QT interval and isolated cases of torsade de pointes has been reported. Avoid use in patients with known prolongation, proarrhythmic conditions such as clinically significant bradycardia or acute myocardial ischemia, hypokalemia, hypomagnesemia, and with drugs that prolong the QT interval.
  • Hypersensitivity and other serious reactions: serious and sometimes fatal reactions, including anaphylactic reactions, may occur after first or subsequent doses of Avelox. Discontinue Moxifloxacin at first sign of skin rash, jaundice or any other sign of hypersensitivity.
  • Clostridium difficile-associated diarrhea: evaluate if diarrhea occurs.


    Adverse reactions, side effects:

    Most common adverse reactions of moxifloxacin ( >= 3%) were nausea, diarrhea, headache, and dizziness.

    To report suspected adverse reactions of Avelox, contact Bayer HealthCare Pharmaceuticals Inc. or your local FDA.


    Drug interactions:

  • Multivalent cation-containing products (including antacids, sucralfate, multivitamins) decreased moxifloxacin absorption. Take Avelox tablet at least 4 hours before or 8 hours after these products.
  • Warfarin: anticoagulant effect enhanced. Monitor prothrombin time/INR, and bleeding.
  • Class IA and Class III antiarrhythmics: proarrhythmic effect may be enhanced. Avoid concomitant use.
  • Antidiabetic agents: carefully monitor blood glucose.


    Use in specific populations:

  • Pregnancy: based on animal data may cause fetal harm.
  • Geriatrics: increased risk for severe tendon disorders further increased by concomitant corticosteroid therapy and increased risk of prolongation of the QT interval.


    Pregnancy categories:

  • B3 - Australia
  • C - United States (Risk cannot be ruled out)


    Salts and other forms:

  • Moxifloxacin Base
  • Moxifloxacin Hydrochloride


    Synonyms, international and chemical names:

  • Mocsifflocsacin
  • Moksifloksacin
  • Moksyfloksacyna
  • Moxifloksacin
  • Moxifloxacina
  • Moxifloxacine
  • Moxifloxacino
  • Moxifloxacinum
  • Moxyfloxacin


    Brands, generics, trade names:

  • Actira - Bayer, BayCare
  • Apdrops - Ajanta Pharma
  • Avalox - Bayer
  • Avelox - Bayer
  • Izilox - Bayer
  • Mediflox - Medico Healthcare
  • Megaxin - Bayer, Perrigo
  • Milflox - Sun Pharmaceutical Industries
  • Moxeza - Alcon
  • Moxibact - Torrent Pharmaceuticals
  • Moxicip - Cipla
  • Moxigram - Micro Labs
  • Octegra - Bayer, Bago Laboratorios, Elpen, Grupo Vita / Vita Cientifica, Recordati
  • Proflox - Therabel Pharma
  • Vigamox - Alcon
  • Zymox - Zodley Pharmaceuticals


    APIs used in medicine in combinations with moxifloxacin:

  • Benzalkonium ChIoride
  • Betamethasone
  • Bromfenac
  • Carboxymethyl Cellulose
  • Cefixime
  • Dexamethasone
  • Difluprednate
  • Hypromellose
  • Ketorolac
  • Loteprednol
  • Mannitol
  • Phenylmercuric Nitrate
  • Prednisolone
  • Tobramycin


    Here is a list of popular medications containing moxifloxacin as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:

    Trade name of the drug Pharmaceutical forms and doses Companies
    Avelox
  • Injectable; Infusion; Moxifloxacin Hydrochloride 400 mg / 250 ml
  • Tablets, Film-Coated; Oral; Moxifloxacin Hydrochloride 400 mg
  • Bayer
  • B & S Healthcare
  • BayHealth Comercializacao de Produtos Farmaceuticos
  • DKSH
  • Fresenius
  • Gen Medicine
  • Maxxcare
  • Merck
  • Zuellig Pharma
  • Moxicip
  • Drops; Ophthalmic; Moxifloxacin Hydrochloride 0.5%
  • Injectable; Infusion; Moxifloxacin Hydrochloride 400 mg / 250 ml
  • Injectable; Infusion; Moxifloxacin Hydrochloride 400 mg / 100 ml
  • Ointment; Ophthalmic; Moxifloxacin Hydrochloride 0.5%
  • Tablets, Film-Coated; Oral; Moxifloxacin Hydrochloride 400 mg
  • Cipla
  • Vigamox
  • Solution; Ophthalmic; Moxifloxacin Hydrochloride 0.5%
  • Alcon
  • Alkem Pharmaceuticals
  • DKSH
  • Firma Chun Cheong
  • Medcor Pharmaceuticals
  • Metro Drug Distribution
  • Novartis
  • Summit
  • Zuellig Pharma



  • References:

  • Moxifloxacin main article on Wikipedia: https://en.wikipedia.org/wiki/Moxifloxacin
  • Moxifloxacin compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Moxifloxacin
  • Moxifloxacin Hydrochloride compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Moxifloxacin-hydrochloride
  • Moxifloxacin base on DrugBank: https://www.drugbank.ca/drugs/DB00218
  • Moxifloxacin Hydrochloride on DrugBank: https://www.drugbank.ca/salts/DBSALT000387
  • Moxifloxacin FAQ on MedlinePlus (revised 07/15/2019): https://medlineplus.gov/druginfo/meds/a600002.html
  • Moxifloxacin Ophthalmic FAQ on MedlinePlus (revised 06/15/2016): https://medlineplus.gov/druginfo/meds/a605016.html
  • Moxifloxacin Injection FAQ on MedlinePlus (revised 07/15/2019): https://medlineplus.gov/druginfo/meds/a608030.html
  • Avelox (Moxifloxacin Hydrochloride) film-coated tablets drug label info on DailyMed (revised August 8, 2011): https://dailymed.nlm.nih.gov/dailymed/lookup...
  • Moxifloxacin Hydrochloride film-coated tablets drug label info on DailyMed (revised December 9, 2020): https://dailymed.nlm.nih.gov/dailymed/lookup...
  • Moxifloxacin containing drugs on Drugs-About.com: https://drugs-about.com/ing/moxifloxacin.html
  • Moxifloxacin for sale on Pharma Doctor: https://pharma-doctor.com/moxifloxacin.html
  • Moxifloxacin international drug names on Drugs.com: https://www.drugs.com/international/moxifloxacin.html
  • Avelox (Moxifloxacin Hydrochloride) tablets and injection for intravenous use official prescribing information and medication guide from the U.S. FDA (revised 07/2016): https://www.accessdata.fda.gov/drugsatfda_docs/label...
  • Avelox (Moxifloxacin Hydrochloride) 400 mg tablets and Avelox I.V. injection 400 mg/250 mL (1.6 mg/mL) for intravenous use product monograph on Bayer pharmaceutical company website (revised February 18, 2020): https://www.bayer.ca/omr/online/avelox-pm-en.pdf
  • Vigamox (Moxifloxacin Hydrochloride) ophthalmic solution 0.5% prescribing information on Novartis pharmaceutical company website (revised 06/2020): https://www.pharma.us.novartis.com/sites/...
  • Moxicip (Moxifloxacin Hydrochloride) 400 mg film-coated tablets prescribing information on Cipla pharmaceutical company website (revised November 2018): https://ciplamed.com/content/moxicip-tablets
  • Moxifloxacin 400 mg film-coated tablets patient information leaflet on Medicines.org.uk (revised November 2020): https://www.medicines.org.uk/emc/files/pil.3273.pdf

    Revised: June 2021



    Home | Overview | Methodology | Respiratory Season Advice | General Conditions of Use | Legal Information | Privacy Statement | Contact Us

    Copyright © 2001 - 2021 Respiratory Tract Infection Alert System by Bayer Corporation. All rights reserved.